Polygenic risk for epigenetic aging and adverse life experiences interact to predict growth in adolescent depression in a racially/ethnically diverse sample

Polygenic risk for epigenetic aging and adverse life experiences interact to predict growth in adolescent depression in a racially/ethnically diverse sample

IntroductionResearch has yet to examine the interplay between indices of environmental risk and resilience processes and genetic predisposition for epigenetic aging in predicting early adolescent depressive symptoms. In the current study we examine whether adverse life events and parental acceptance...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kit K. Elam, Jinni Su, Weisiyu Abraham Qin, Kathryn Lemery-Chalfant
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Psychiatry
Subjects:	polygenic epigenetics depression adverse life events parent acceptance early adolescence
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1499395/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Polygenic diseases
by: Sergey Dolomatov, et al.
Published: (2025-01-01)

Polygenic prediction of human longevity on the supposition of pervasive pleiotropy
by: M. Reza Jabalameli, et al.
Published: (2024-08-01)

Risk of adverse cardiovascular events based on common genetic variants in 8-year follow-up of the LIPIDOGEN2015 population using the polygenic risk score (PRS): study design and methodology
by: Maciej Banach, et al.
Published: (2024-08-01)

Risk factors affecting polygenic score performance across diverse cohorts
by: Daniel Hui, et al.
Published: (2025-01-01)

Parental epigenetic age acceleration and risk of adverse birth outcomes: the Norwegian mother, father and child cohort study
by: Maria C. Magnus, et al.
Published: (2024-11-01)

Association of polygenic scores for autism with volumetric MRI phenotypes in cerebellum and brainstem in adults
by: Salahuddin Mohammad, et al.
Published: (2024-08-01)

Polygenic Genetic Analysis of Principal Genes for Yield Traits in Land Cotton
by: Xiaoman Ma, et al.
Published: (2024-11-01)

Development and evaluation of patient-centred polygenic risk score reports for glaucoma screening
by: Georgina L Hollitt, et al.
Published: (2025-01-01)

Alzheimer's polygenic hazard score in SuperAgers: SuperGenes or SuperResilience?
by: Barbara E. Spencer, et al.
Published: (2022-01-01)

Benchmarking Alzheimer’s disease prediction: personalised risk assessment using polygenic risk scores across various methodologies and genome-wide studies
by: Eftychia Bellou, et al.
Published: (2025-01-01)

Enhancing the utility of polygenic scores in Alzheimer’s disease through systematic curation and annotation
by: Savannah Mwesigwa, et al.
Published: (2025-02-01)

Relationships between the Planetary Health Diet Index, its food groups, and polygenic risk of obesity in the CARTaGENE cohort
by: Guiomar Masip, et al.
Published: (2024-12-01)

Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction
by: Kristia Yiangou, et al.
Published: (2024-12-01)

Effects of the Interaction Between Oxidative Balance Score and Polygenic Risk Scores on Incidence of Metabolic Syndrome in Middle-Aged Korean Adults
by: Minyeong Kim, et al.
Published: (2024-12-01)

Investigating the effect of polygenic background on epilepsy phenotype in ‘monogenic’ familiesResearch in context
by: Karen L. Oliver, et al.
Published: (2024-11-01)

Interplay between lifestyle factors and polygenic risk for incident coronary heart disease in a large multiethnic cohort
by: Carlos Iribarren, et al.
Published: (2024-12-01)

Evaluate the renal system damage caused by zoledronic acid: a comprehensive analysis of adverse events from FAERS
by: Zhaojun Wang, et al.
Published: (2024-12-01)

Socioeconomic disadvantage and polygenic risk of overweight in early and mid-life: a longitudinal population cohort study spanning 12 yearsResearch in context
by: Jessica A. Kerr, et al.
Published: (2024-12-01)

Genetic Analysis of Flowering Time in Pansies Using Mixed Major Gene Plus Polygene Inheritance Model
by: Jiayi Liu, et al.
Published: (2024-12-01)

Patient Perspectives on Personalized Risk Communication Using Polygenic Risk Scores to Inform Colorectal Cancer Screening Decisions
by: Shauna R. Goldberg, MPH, et al.
Published: (2025-02-01)

The clinical value and most informative threshold of polygenic risk score in the Quebec City Case-Control Asthma Cohort
by: Martin Pariès, et al.
Published: (2025-01-01)

Polygenic Risk Score Improves Melanoma Risk Assessment in a Patient Cohort from the Veneto Region of Italy
by: Stefania Pellegrini, et al.
Published: (2024-11-01)

PSA LEVEL AND ADVERSE EVENTS IN SIXTH AND TENTH SERIES DOCETAXEL CHEMOTHERAPY IN CASTRATE-RESISTANT PROSTATE CANCER (CRPC) PATIENTS
by: Kurnia Penta Seputra, et al.
Published: (2025-01-01)

Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system
by: Jingrong Yang, et al.
Published: (2025-01-01)

Genetic confounds of transgenerational epigenetic inheritance in mice
by: Daniel M. Sapozhnikov, et al.
Published: (2024-12-01)

Real-world study of adverse events associated with triptan use in migraine treatment based on the U.S. Food and Drug Administration (FDA) adverse event reporting system (FAERS) database
by: Wen-Hui Liu, et al.
Published: (2024-11-01)

Blood Lipid Polygenic Risk Score Development and Application for Atherosclerosis Ultrasound Parameters
by: Marija Zaicenoka, et al.
Published: (2024-12-01)

Pharmacovigilance study of famciclovir in the Food and Drug administration adverse event reporting system database
by: Runan Fang, et al.
Published: (2024-11-01)

Rare immune-related adverse events in patients with melanoma: incidence, spectrum, and clinical presentations
by: Benjamin C. Park, et al.
Published: (2023-12-01)

A decade-long overview of adverse events in a tertiary surgical service in South Africa
by: H Wain, et al.
Published: (2024-10-01)

Calling the question: what is mammalian transgenerational epigenetic inheritance?
by: Hasan Khatib, et al.
Published: (2024-12-01)

Methylation patterns associated with C-reactive protein in racially and ethnically diverse populations
by: Jessica I. Lundin, et al.
Published: (2024-12-01)

A real−world pharmacovigilance study of FDA Adverse Event Reporting System events for pralsetinib
by: Yi Yin, et al.
Published: (2024-11-01)

Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
by: Shiyi Wang, et al.
Published: (2025-02-01)

The Efficacy and Adverse Effects of Topiramate in Add on Therapy in Children with Intractable Epilepsy
by: Özlem Özdemir, et al.
Published: (2009-12-01)

Drug-induced retinal vein occlusion: a disproportionality analysis from the FDA adverse event reporting system (2004–2023)
by: Xiao-Dong Chen, et al.
Published: (2024-12-01)

Faecal microbiota transplantation associated adverse events
by: Patryn Rafal, et al.
Published: (2024-09-01)

Adverse event profile of lorazepam: a real-world pharmacovigilance study using the FDA adverse event reporting system database
by: Zhengkang Su, et al.
Published: (2024-11-01)

Pharmacovigilance study of the association between progestogen and depression based on the FDA adverse event reporting System (FAERS)
by: Hui Gao, et al.
Published: (2025-01-01)

Enduring memory consequences of early-life stress / adversity: Structural, synaptic, molecular and epigenetic mechanisms
by: Tallie Z. Baram, et al.
Published: (2024-11-01)